RCUS Earnings Arcus Biosciences, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Revenue
Net income
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–22 of 22
| Q2 2026 | 2026-06-30 | -1.74 | 2026-08-05 | 10-Q |
| Q1 2026 | 2026-03-31 | -1.02 | 2026-05-05 | 10-Q |
| FY 2025 | 2025-12-31 | -3.29 | 2026-02-25 | 10-K |
| Q3 2025 | 2025-09-30 | -2.39 | 2025-10-28 | 10-Q |
| Q2 2026 | 2025-06-30 | -1.09 | 2026-08-05 | 10-Q |
| Q1 2026 | 2025-03-31 | -1.14 | 2026-05-05 | 10-Q |
| FY 2025 | 2024-12-31 | -3.14 | 2026-02-25 | 10-K |
| Q3 2025 | 2024-09-30 | -2.11 | 2025-10-28 | 10-Q |
| Q2 2025 | 2024-06-30 | -1.09 | 2025-08-06 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.05 | 2025-05-06 | 10-Q |
| FY 2025 | 2023-12-31 | -4.15 | 2026-02-25 | 10-K |
| Q3 2024 | 2023-09-30 | -3.07 | 2024-11-06 | 10-Q |
| Q2 2024 | 2023-06-30 | -2.13 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -1.09 | 2024-05-08 | 10-Q |
| FY 2024 | 2022-12-31 | -3.71 | 2025-02-25 | 10-K |
| Q3 2022 | 2022-09-30 | -2.78 | 2022-11-02 | 10-Q |
| FY 2023 | 2021-12-31 | 0.71 | 2024-02-21 | 10-K |
| Q3 2022 | 2021-09-30 | -3.28 | 2022-11-02 | 10-Q |
| FY 2022 | 2020-12-31 | -2.24 | 2023-02-28 | 10-K |
| Q3 2021 | 2020-09-30 | -1.37 | 2021-11-08 | 10-Q |
| FY 2021 | 2019-12-31 | -1.93 | 2022-02-23 | 10-K |
| Q3 2020 | 2019-09-30 | -1.56 | 2020-11-05 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.